Site Search

April is National Minority Health Month. One of our priorities at the American Cancer Society Cancer Action Network (ACS CAN) is supporting public policies that work to ... lawmakers to support legislation aimed at sustaining NIH funding levels, reducing financial burdens on patients and ultimately eliminating health disparities, ACS CAN joined three of our public health and research partners to co-host a Congressional briefing last month. The briefing, ... and control, this focus is particularly relevant. Over and over again, research studies have shown significant differences in access to cancer care and the quality of treatment received in minority and vulnerable populations. Achieving the highest level of health for everyone will require ...

Washington, D.C.—Cancer patients and those who’ve recently completed treatment are finding it challenging to get necessary health care in the midst of the COVID-19 pandemic and many are experiencing financial stress trying to afford care in an increasingly difficult economic ... services to determine if a patient’s cancer had grown or returned (20%); access to supportive services, including physical therapy or mental health care (20%); and access to surgical procedures (8%). Among just the respondents who remain in active treatment, more than a quarter (27%) ...

Washington, D.C.—Cancer patients and those who’ve recently completed treatment are finding it challenging to get necessary health care in the midst of the COVID-19 pandemic and many are experiencing financial stress trying to afford care in an increasingly difficult economic ... services to determine if a patient’s cancer had grown or returned (20%); access to supportive services, including physical therapy or mental health care (20%); and access to surgical procedures (8%). Among just the respondents who remain in active treatment, more than a quarter (27%) ...

... can be Attributed to Leo Almeida, American Cancer Society Cancer Action Network (ACS CAN) government relations director: “To improve access to care for those who hear the words 'you have cancer,' ACS CAN calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment and testing.  “To further improve access to care ...